Literature DB >> 18804916

The dynamic mechanisms of placebo induced analgesia: Evidence of sustained and transient regional involvement.

Jason G Craggs1, Donald D Price, William M Perlstein, Nicholas G Verne, Michael E Robinson.   

Abstract

Previously, we demonstrated that placebo analgesia (PA) accompanies reductions in neural activity during painful stimulation. This study investigated areas of the brain where the neural activity was increased during PA. The literature has associated PA with two potential mechanisms of action; one sustained (e.g., engaged for the duration of PA), the other, transitory (e.g., a feedback mechanism). We propose that PA results from the engagement of two complementary pain-modulation mechanisms that are identified with fMRI data as a main effect for condition or a time *condition interaction. The mechanism with sustained activity should activate the emotional regulation circuitry needed for memory formation of the event. The mechanism with transient activity should process cognitive and evaluative information of the stimuli in the context of the placebo suggestion to confirm the expectations set by it. To identify regions involved with these mechanisms, we re-analyzed fMRI data from two conditions: baseline (B) and PA. Results support the presence of both mechanisms, identified as two neural-networks with different temporal characteristics. Regions with sustained activity primarily involved the temporal and parahippocampal cortices. Conversely, brain regions with transient activity included linguistic centers in the left hemisphere and frontal regions of the right hemisphere generally associated with executive functioning. Together, these mechanisms likely engage analgesic processes and then simply monitor the system for unexpected stimuli, effectively liberating resources for other processes. Identifying brain regions associated with pain-modulation with different temporal profiles is consistent with the multidimensionality of PA and highlights the need for continued investigation of this construct.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804916      PMCID: PMC2723185          DOI: 10.1016/j.pain.2008.07.025

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  25 in total

1.  Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging.

Authors:  Jian Kong; Randy L Gollub; Ilana S Rosman; J Megan Webb; Mark G Vangel; Irving Kirsch; Ted J Kaptchuk
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

2.  Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients.

Authors:  Donald D Price; Jason Craggs; G Nicholas Verne; William M Perlstein; Michael E Robinson
Journal:  Pain       Date:  2006-09-08       Impact factor: 6.961

Review 3.  Central nervous system mechanisms of analgesia.

Authors:  David J Mayer; Donald D Price
Journal:  Pain       Date:  1976-12       Impact factor: 6.961

4.  Classical conditioning and the placebo effect.

Authors:  G H Montgomery; I Kirsch
Journal:  Pain       Date:  1997-08       Impact factor: 6.961

Review 5.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.

Authors:  A I Basbaum; H L Fields
Journal:  Annu Rev Neurosci       Date:  1984       Impact factor: 12.449

6.  Somatotopic activation of opioid systems by target-directed expectations of analgesia.

Authors:  F Benedetti; C Arduino; M Amanzio
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

7.  Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms.

Authors:  Lene Vase; Michael E Robinson; G Nicholas Verne; Donald D Price
Journal:  Pain       Date:  2005-06       Impact factor: 6.961

8.  Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome.

Authors:  G Nicholas Verne; Nathan C Himes; Michael E Robinson; Kaundinya S Gopinath; Richard W Briggs; Bruce Crosson; Donald D Price
Journal:  Pain       Date:  2003-05       Impact factor: 6.961

9.  Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

Authors:  H Mertz; B Naliboff; J Munakata; N Niazi; E A Mayer
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

10.  Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.

Authors:  G Nicholas Verne; Richard H Davis; Michael E Robinson; James M Gordon; Ervin Y Eaker; Charles A Sninksy
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  27 in total

1.  Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain.

Authors:  Martina Amanzio; Fabrizio Benedetti; Carlo A Porro; Sara Palermo; Franco Cauda
Journal:  Hum Brain Mapp       Date:  2011-11-29       Impact factor: 5.038

2.  Individual expectation: an overlooked, but pertinent, factor in the treatment of individuals experiencing musculoskeletal pain.

Authors:  Joel E Bialosky; Mark D Bishop; Joshua A Cleland
Journal:  Phys Ther       Date:  2010-06-30

3.  A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider communication.

Authors:  Maria E Suarez-Almazor; Carol Looney; Yanfang Liu; Vanessa Cox; Kenneth Pietz; Donald M Marcus; Richard L Street
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-09       Impact factor: 4.794

4.  Behavioural and neural evidence for self-reinforcing expectancy effects on pain.

Authors:  Marieke Jepma; Leonie Koban; Johnny van Doorn; Matt Jones; Tor D Wager
Journal:  Nat Hum Behav       Date:  2018-10-29

Review 5.  Patients' direct experiences as central elements of placebo analgesia.

Authors:  Lene Vase; Kathrine Næsted Nørskov; Gitte Laue Petersen; Donald D Price
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

6.  Enhancing the placebo response: functional magnetic resonance imaging evidence of memory and semantic processing in placebo analgesia.

Authors:  Jason G Craggs; Donald D Price; Michael E Robinson
Journal:  J Pain       Date:  2014-01-09       Impact factor: 5.820

7.  Psychological and sensory predictors of experimental thermal pain: a multifactorial model.

Authors:  Christopher J Starr; Timothy T Houle; Robert C Coghill
Journal:  J Pain       Date:  2010-06-08       Impact factor: 5.820

8.  Pain measurement and brain activity: will neuroimages replace pain ratings?

Authors:  Michael E Robinson; Roland Staud; Donald D Price
Journal:  J Pain       Date:  2013-04       Impact factor: 5.820

Review 9.  Understanding placebo and nocebo responses for pain management.

Authors:  Luana Colloca; Christian Grillon
Journal:  Curr Pain Headache Rep       Date:  2014-06

10.  Placebo conditioning and placebo analgesia modulate a common brain network during pain anticipation and perception.

Authors:  Alison Watson; Wael El-Deredy; Gian Domenico Iannetti; Donna Lloyd; Irene Tracey; Brent A Vogt; Valerie Nadeau; Anthony K P Jones
Journal:  Pain       Date:  2009-06-11       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.